Jake Robertson

Jake Robertson


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Cancers
Verified
Journal Article
Open access
PDF file
JRJake Robertson
Jake Robertson
CJCheryl L. Jorcyk
Cheryl L. Jorcyk
Julia OxfordJulia Oxford
Julia Oxford
DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed.

4 January 2025 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
CNCassidy M. Nguyen
Cassidy M. Nguyen
JRJake Robertson
Jake Robertson
ACAdam Cardenas
Adam Cardenas
EMEdgar Martinez
Edgar Martinez
BKBrett H. Keeling
Brett H. Keeling
KNKhang D. Nguyen
Khang D. Nguyen

1 August 2019
Verified
Journal Article
Closed access
JRJake Robertson
Jake Robertson
MSMaryam Safaee
Maryam Safaee
FLFan Liu
Fan Liu
MSMichi M Shinohara
Michi M Shinohara

1 November 2024 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
CNCassidy M. Nguyen
Cassidy M. Nguyen
MTMika M. Tabata
Mika M. Tabata
JRJake Robertson
Jake Robertson
BKBrett Keeling
Brett Keeling
MBMargaret Brown
Margaret Brown

6 June 2021 in Cureus
Verified
Journal Article
Open access
JRJake Robertson
Jake Robertson
MJMustufa A Jafry
Mustufa A Jafry
LSLori Soma
Lori Soma
ASAndrei Shustov
Andrei Shustov
MSMichi M Shinohara
Michi M Shinohara
Sézary syndrome (SS) is a form of cutaneous T-cell lymphoma (CTCL), demonstrating leukemic involvement of malignant T-cells. Known systemic sequelae of SS include hemophagocytic syndrome-induced anemia, normocytic anemia secondary to bone marrow infiltration, and pancytopenia. We report a patient with SS, initially demonstrating widespread morbilliform eruption, who presented with malignancy-related microangiopathic hemolytic anemia (MAHA). Our findings represent a novel presentation of SS that will inform the differential diagnosis and treatment of future SS patients presenting with anemia and thrombocytopenia.